Cart
sales@molnova.com
VU-1545
CAS No. 890764-63-3
VU-1545( VU 1545 )
Catalog No. M27735 CAS No. 890764-63-3
VU 1545 is mGlu5 positive allosteric modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 102 | Get Quote |
|
| 5MG | 145 | Get Quote |
|
| 10MG | 209 | Get Quote |
|
| 25MG | 480 | Get Quote |
|
| 50MG | 692 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 500MG | 1944 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVU-1545
-
NoteResearch use only, not for human use.
-
Brief DescriptionVU 1545 is mGlu5 positive allosteric modulator.
-
DescriptionVU 1545 is mGlu5 positive allosteric modulator.
-
In VitroVU-1545 (10 and 100 μM) promotes AKT activation. VU-1545 at the concentrations of 0.1 and 1.0 μM efficiently promots Akt activation above basal levels Western Blot Analysis Cell Line:Neuronal cells Concentration:10 and 100 μM Incubation Time:5 minutes Result:Promoted Akt phosphorylation as efficiently at the concentration of 10.0 μM as at the concentration of 100.0 μM.
-
In Vivo——
-
SynonymsVU 1545
-
PathwayNeuroscience
-
TargetGluR
-
RecptorMicrobial Metabolite|TGR5|FXR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number890764-63-3
-
Formula Weight402.385
-
Molecular FormulaC22H15FN4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (248.52 mM)
-
SMILES[O-][N+](=O)c1ccc(cc1)C(=O)Nc1cc(nn1-c1ccccc1F)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jones H, Alpini G, Francis H. Bile acid signaling and biliary functions. Acta Pharm Sin B. 2015 Mar;5(2):123-8.
molnova catalog
related products
-
CNQX
CNQX is a competitive non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 μM for AMPA and kainate receptors respectively).
-
VU 29
VU-29 is a positive allosteric mGlu5 receptor modulator with EC50=9 nM and Ki=244 nM for rmGluR5.
-
Ginsenoside Ro
GinsenosideRo exhibits a Ca2+-antagonistic antiplatelet effect.
